CryoPortCYRX
CYRX
About: CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Employees: 1,186
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
10% more call options, than puts
Call options by funds: $2M | Put options by funds: $1.83M
3.88% less ownership
Funds ownership: 95.73% [Q4 2024] → 91.86% (-3.88%) [Q1 2025]
5% less funds holding
Funds holding: 160 [Q4 2024] → 152 (-8) [Q1 2025]
11% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 55
20% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 25
24% less capital invested
Capital invested by funds: $368M [Q4 2024] → $279M (-$89.4M) [Q1 2025]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$7
7%
downside
Avg. target
$9.50
26%
upside
High target
$11
46%
upside
4 analyst ratings
3 positive
75%
1 neutral
25%
0 negative
0%
BTIG David Larsen | 32%upside $10 | Buy Maintained | 7 Jul 2025 |
Needham David Saxon | 46%upside $11 | Buy Reiterated | 8 May 2025 |
Morgan Stanley Tejas Savant | 7%downside $7 | Equal-Weight Maintained | 5 May 2025 |
Guggenheim Subbu Nambi | 32%upside $10 | Buy Reiterated | 16 Apr 2025 |
Financial journalist opinion
Based on 7 articles about CYRX published over the past 30 days
Neutral
PRNewsWire
3 days ago
Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers
New SC vapor shipper series improves reliability through extended hold times and patented impact-absorbing and Vapor Shield Technology NASHVILLE, Tenn. , July 8, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' new vapor shippers, the SC 4/2V and SC 4/3V, offering medical and animal health professionals, laboratories, researchers, hospitals and clinics, pharmaceutical companies, and others dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures.
Positive
Zacks Investment Research
1 week ago
What Makes CryoPort, Inc. (CYRX) a Strong Momentum Stock: Buy Now?
Does CryoPort, Inc. (CYRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Neutral
The Motley Fool
1 week ago
CEO Jerrell Shelton Sells Some Shares of Cryoport (CYRX)
According to the SEC Form 4 filing on June 26, 2025, Jerrell Shelton, president and CEO, exercised $5 per share options on 16,344 shares of Cryoport (CYRX 0.68%) and proceeded to sell them at $7.0586 per share (on average) on June 24, 2025, for a total sale price of $115,365.
Neutral
The Motley Fool
1 week ago
CEO Jerrell Shelton Sells Some Shares of Cryoport (CYRX)
According to the SEC Form 4 filing on June 26, 2025, Jerrell Shelton, President and CEO, exercised $5 per share options on 16,344 shares of Cryoport (CYRX 4.18%) and proceeded to sell them at $7.0586 per share (on average) on June 24, 2025, for a total sale price of $115,365.
Neutral
The Motley Fool
1 week ago
CEO Jerrell Shelton Sells Some Shares of Cryoport (CYRX)
According to the SEC Form 4 filing on June 26, 2025, Jerrell Shelton, president and CEO, exercised $5 per share options on 16,344 shares of Cryoport (CYRX 1.62%) and proceeded to sell them at $7.0586 per share (on average) on June 24, 2025, for a total sale price of $115,365.
Positive
Zacks Investment Research
2 weeks ago
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know
CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Neutral
PRNewsWire
4 weeks ago
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
NASHVILLE, Tenn. , June 12, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain solutions for the Life Sciences, with a focus on regenerative medicine, today announced the completion of the previously disclosed divestiture of its specialty courier business, CRYOPDP, to DHL Group ("DHL"), one of the world's leading logistics providers, in a transaction that includes cash payments of approximately $200 million to Cryoport.
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Positive
Zacks Investment Research
1 month ago
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Neutral
Seeking Alpha
2 months ago
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Kyle Crews - UBS Richard Baldry - ROTH Capital David Larsen - BTIG Subbu Nambi - Guggenheim Securities Matt Stanton - Jefferies Anna Snopkowski - KeyBanc Operator Good afternoon, and welcome to Cryoport's First Quarter 2025 Earnings Call. All participants will start in a listen-only mode.
Charts implemented using Lightweight Charts™